phosphatidylcholines has been researched along with ml-3000 in 1 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (ml-3000) | Trials (ml-3000) | Recent Studies (post-2010) (ml-3000) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 130 | 9 | 56 |
| Protein | Taxonomy | phosphatidylcholines (IC50) | ml-3000 (IC50) |
|---|---|---|---|
| Prostaglandin E synthase | Homo sapiens (human) | 6.14 | |
| Prostaglandin G/H synthase 1 | Bos taurus (cattle) | 0.1925 | |
| Prostaglandin G/H synthase 2 | Bos taurus (cattle) | 0.21 | |
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 0.185 | |
| Polyunsaturated fatty acid 5-lipoxygenase | Homo sapiens (human) | 0.3017 | |
| Polyunsaturated fatty acid 5-lipoxygenase | Rattus norvegicus (Norway rat) | 3.6 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 2.7425 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.422 | |
| 5-lipoxygenase | Bos taurus (cattle) | 0.47 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, M; Martel-Pelletier, J; Pelletier, JP; Rahman, P; Randell, EW; Zhai, G | 1 |
1 trial(s) available for phosphatidylcholines and ml-3000
| Article | Year |
|---|---|
Serum lysophosphatidylcholines to phosphatidylcholines ratio is associated with symptomatic responders to symptomatic drugs in knee osteoarthritis patients.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Cyclooxygenase Inhibitors; Female; Humans; Lysophosphatidylcholines; Male; Middle Aged; Naproxen; Osteoarthritis, Knee; Phosphatidylcholines; Pyrroles; Treatment Outcome | 2019 |